RecruitingPhase 4NCT06833788

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression: a Multicentric Randomized Open-labelled Controlled Trial

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

2,860 participants

Start Date

Oct 22, 2025

Study Type

INTERVENTIONAL

Conditions

Postpartum Depression (PPD)

Summary

The objectif of the IRON-DEP Study is to assess the efficacy of intravenous (IV) versus oral iron treatment on the prevalence of postpartum depression (PPD) in women with moderate iron deficiency anemia after caesarean delivery.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ferric carboxymaltose IV and a drug called TIMOFÉROL® for people with postpartum depression (ppd). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.